In conclusion, CAB is effective in lowering PRL and androgen levels while improving menstrual regularity in both PCOS and prolactinoma patients, highlighting its potential as a valuable therapeutic option for PCOS with elevated PRL cases. Here, PRL is linked to polycystic ovary syndrome.